Oxidative derangement in rat synaptosomes induced by hyperglycaemia: Restorative effect of dehydroepiandrosterone treatment

Biochemical Pharmacology

Volumn 60, Issue 3, 2000, Pages 389-395

  Aragno, Manuela ^a   Parola, Silvia ^a   Tamagno, Elena ^a   Brignardello, Enrico ^a   Manti, Roberta ^a   Danni, Oliviero ^a   Boccuzzi, Giuseppe ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Antioxidant; Dehydroepiandrosterone; Hyperglycaemia; NaK ATPase; Oxidative damage; Synaptosomes

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ALPHA TOCOPHEROL; GLUTATHIONE; PRASTERONE; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; ENZYME ACTIVITY; HYPERGLYCEMIA; LIPID PEROXIDATION; MALE; NERVE INJURY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SYNAPTIC MEMBRANE; SYNAPTOSOME;

ANIMALS; ANTIOXIDANTS; AXONS; CELL MEMBRANE; DEHYDROEPIANDROSTERONE; DIABETES MELLITUS, EXPERIMENTAL; FREE RADICALS; HYPERGLYCEMIA; LIPID PEROXIDATION; MALE; OXIDATION-REDUCTION; RATS; RATS, WISTAR; STREPTOZOCIN; SYNAPTOSOMES;

EID: 0034257193     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(00)00327-0     Document Type: Article

References (57)

1. Berger L., Hakim M. The association of hyperglycemia with cerebral edema in stroke. Stroke. 17:1986;865-871.
2. Barzilay J.I., Kronmal R.A., Bittner V., Eaker E., Foster E.D. Coronary artery disease in diabetic and nondiabetic patients with lower extremity arterial disease A report from the Coronary Artery Surgery Study Registry . Am Heart J. 135:1998;1055-1062.
3. Swidan S.Z., Montgomery P.A. Effect of blood glucose concentrations on the development of chronic complications of diabetes mellitus. Pharmacotherapy. 18:1998;961-972.
4. Li P.A., Gisselsson L., Keuker J., Vogel J., Smith M.L., Kuschinsky W., Siesjo B.K. Hyperglycemia-exaggerated ischemic brain damage following 30 min of middle cerebral artery occlusion is not due to capillary obstruction. Brain Res. 804:1998;36-44.
5. Oberley L.W. Free radicals and diabetes. Free Radic Biol Med. 5:1988;113-124.
6. Hunt J.V. Glucose Chemistry and atherosclerosis in diabetes mellitus . Nohl H., Esterbauer H., Rice-Evans C. Free Radicals in the Environment, Medicine and Toxicology. 1994;137-162 Richelieu Press, London.
7. Kumar J.S., Menon V.P. Effect of diabetes on levels of lipid peroxides and glycolipids in rat brain. Metabolism. 42:1993;1435-1439.
8. Kawai N., Keep R.P., Betz A.L., Nagao S. Hyperglycemia induces progressive changes in the cerebral microvasculature and blood-brain barrier transport during focal cerebral ischemia. Acta Neurochir Suppl(Wien). 71:1998;219-221.
9. Karasu C., Dewhurst M., Stevens E.J., Tomlinson D.R. Effect of anti-oxidant treatment on sciatic nerve dysfunction in streptozotocin-diabetic rats; Comparison with essential fatty acid. Diabetologia. 38:1995;129-134.
10. Markesbery W.R., Lovell M.A. Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease. Neurobiol Aging. 19:1998;33-36.
11. Selley M.L. (E)-4-hydroxy-2-nonenal may be involved in the pathogenesis of Parkinson's disease. Free Radic Biol Med. 25:1998;169-174.
12. Low P.A., Nickander K.K., Tritschler H.J. The roles of oxidative stress and antioxidant treatment in experimental diabetic neuropathy. Diabetes. 46:1997;S38-S42.
13. Urano S., Asai Y., Makabe S., Matsuo M., Izumiyama N., Ohtsubo K., Endo T. Oxidative injury of synapse and alteration of antioxidative defence systems in rats, and its prevention by vitamin E. Eur J Biochem. 245:1997;64-70.
14. Vatassary G.T., Vitamin E. and other endogenous antioxidants in the central nervous system. Geriatrics. 53:1998;S25-S27.
15. Baulieu E.E., Robel P., Vatier O., Haug A., Le Goascogne C., Borreau E. Fuxe K., Agnati L.F. Receptor-Receptor Interaction, A New Intramembrane Integrative Mechanism. 1987;89-194 Macmillan, Basingstoke.
16. Zwain I.H., Yen S.S. Dehydroepiandrosterone Biosynthesis and metabolism in the brain . Endocrinology. 140:1999;880-887.
17. Bologa L., Sharma J., Roberts E. Dehydroepiandrosterone and its sulfated derivative reduce neuronal death and enhance astrocytic differentiation in brain cell cultures. J Neurosci Res. 17:1987;225-234.
18. Majewska M.D. Neuronal actions of dehydroepiandrosterone. Possible roles in brain development, aging, memory, and affect. Ann N Y Acad Sci. 774:1995;111-120.
19. Swierczynski J., Bannasch P., Mayer D. Increase of lipid peroxidation in rat liver microsomes by dehydroepiandrosterone feeding. Biochim Biophys Acta. 1315:1996;193-198.
20. Waxman DJ, Role of metabolism in the activation of dehydroepiandrosterone as a peroxisome proliferator. J Endocrinol150 Suppl: S129-S147, 1996.
21. Arad Y., Badimon J.J., Badimon L., Hembree W.C., Ginsberg H.N. Dehydroepiandrosterone feeding prevents aortic fatty streak formation and cholesterol accumulation in cholesterol-fed rabbit. Arteriosclerosis. 9:1989;159-166.
22. Aragno M., Tamagno E., Boccuzzi G., Brignardello E., Chiarpotto E., Pizzini A., Danni O. Dehydroepiandrosterone pretreatment protects rats against the pro-oxidant and necrogenic effects of carbon tetrachloride. Biochem Pharmacol. 46:1993;1689-1694.
23. Boccuzzi G., Aragno M., Seccia M., Brignardello E., Tamagno E., Albano E., Danni O., Bellomo G. Protective effect of dehydroepiandrosterone against copper-induced lipid peroxidation in the rat. Free Radic Biol Med. 22:1997;1289-1294.
24. Kimonides V.G., Khatibi N.H., Svendsen C.N., Sofroniew M.V., Herbert J. Dehydroepiandrosterone (DHEA) and DHEA-S (DHEA-S) protect hippocampal neurones against excitatory amino acid-induced neurotoxicity. Proc Natl Acad Sci USA. 17:1998;1852-1857.
25. Aragno M., Brignardello E., Tamagno E., Gatto V., Danni O., Boccuzzi G. Dehydroepiandrosterone administration prevents the oxidative damage induced by acute hyperglycemia in rats. J Endocrinol. 158:1997;21-26.
26. Brignardello E., Beltramo E., Molinatti P.A., Aragno M., Gatto V., Tamagno E., Danni O., Porta M., Boccuzzi G. Dehydroepiandrosterone protects bovine retinal capillary pericytes against glucose toxicity. J Endocrinol. 158:1998;21-26.
27. Aragno M, Tamagno E, Gatto V, Brignardello E, Parola S, Danni O and Boccuzzi G, Dehydroepiandrosterone protects tissues of streptozotocin-treated rats against oxidative stress. Free Radic Biol Med 26: 1467-1474, 1999.
28. Whittaker VP, Membranes in synaptic function. In: Cell Membranes. Biochemistry, Cell Biology and Pathology (Eds. Weissmann G and Claiborne R), pp. 167-175. Hospital Practice Publishing Co., Inc., New York, 1975.
29. Hajos F. An improved method for the preparation of synaptosomal fractions in high purity. Brain Res. 93:1975;485-489.
30. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the folin phenol reagent. J Biol Chem. 193:1951;265-275.
31. Lai J.C., Clark J.B. Preparation and properties of mitochondria derived from synaptosomes. Biochem J. 154:1976;423-432.
32. Boccuzzi G., Brignardello E., Massobrio M., Bonino L. Breast duct fluid dehydroepiandrosterone sulfate in fibrocystic disease. Eur J Cancer Clin Oncol. 23:1987;1099-1102.
33. Owens C.W., Belcher R.V. A colorimetric micro-method for the determination of glutathione. Biochem J. 94:1965;705-711.
34. Burton G.W., Webb A., Ingold K.U. A mild, rapid and efficient method of lipid extraction for use in determining vitamin E/lipid ratios. Lipids. 20:1985;29-39.
35. Folch J., Lees M., Sloane Stanley G.H. A simple method for the isolation and purification of total lipids from animals tissues. J Biol Chem. 226:1957;497-509.
36. Esterbauer H., Koller E., Slee R.G., Koster J.F. Possible involvement of the lipid peroxidation product 4-hydroxynonenal in the formation of fluorescent chromolipids. Biochem J. 239:1986;405-409.
37. Halliwell B. How to characterize a biological antioxidant. Free Radic Res Commun. 9:1990;1-32.
38. Ravindranath V. Animal models and molecular markers for cerebral ischemia-reperfusion injury in brain. Packer L. Methods in Enzymology. Vol. 233:1994;610-619 Academic Press, New York.
39. 2+ activated hydrogen peroxide production in synaptosomes. Biochim Biophys Acta. 1176:1993;208-214.
40. Zoccarato F., Deana R., Cavallini L., Alexandre A. Generation of hydrogen peroxide by cerebral-cortex synaptosomes. Stimulation by ionomycin and plasma-membrane depolarization. Eur J Biochem. 180:1989;473-478.
41. Shallom J.M., Katyare S.S. Altered synaptosomal ATPase activity in rat brain following prolonged in vivo treatment with nicotine. Biochem Pharmacol. 34:1985;3445-3449.
42. Morgan T.E., Hanahan D.J., Ekholm J. A rapid method for deacylation of phospholipids and neutral lipids. Fed Proc. 22:1963;414-417.
43. nd Revised Ed., pp. 134-140. Karger, Basel, 1988.
44. Vermeulen A. Dehydroepiandrosterone sulfate and aging. Ann N Y Acad Sci. 774:1995;121-127.
45. Koh J., Choi D. Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay. J Neurosci Methods. 20:1987;83-90.
46. Shin C.S., Lee M.K., Park K.S., Kim S.Y., Cho B.Y., Lee H.K., Koh C.S., Min M.K. Insulin restores fatty acid composition earlier in liver microsomes than erythrocyte membranes in streptozotocin-induced diabetic rats. Diabetes Res Clin Pract. 29:1995;93-98.
47. Kuwahara Y., Yanagishita T., Konno N., Katagiri T. Changes in microsomal membrane phospholipids and fatty acids and in activities of membrane-bound enzyme in diabetic rat heart. Basic Res Cardiol. 92:1997;214-222.
48. Braughler J.M., Hall E.D. Central nervous system trauma and stroke. I. Biochemical consideration for oxygen radical formation and lipid peroxidation. Free Radic Biol Med. 6:1989;289-301.
49. Baynes J.W. Role of oxidative stress in development of complications in diabetes. Diabetes. 40:1991;405-412.
50. Cameron N.E., Cotter M.A., Maxfield E.K. Anti-oxidant treatment prevents the development of peripheral nerve dysfunction in streptozotocin-diabetic rats. Diabetologia. 36:1993;299-304.
51. Hu M.L., Ng H.P., Shih M.K. Hemolytic effects of dehydroepiandrosterone in vitro. Life Sci. 61:1997;2137-2142.
52. Mohan P., Clearly M. Short-term effects of dehydroepiandrosterone treatment in rats on mitochondrial respiration. J Nutr. 121:1991;240-250.
53. Esterbauer H., Schaur R.J., Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med. 11:1991;81-128.
54. 2+-ATPase activities in different regions of rat brain during alloxan diabetes. J Neurochem. 39:1982;903-908.
55. +-ATPase isoenzymes in the rat diabetic neuropathy Protective effect of dietary supplementation with n-3 fatty acids . J Neurochem. 71:1998;732-740.
56. Greene D.A., Lattimer S.A., Carroll P.B., Fernstrom J.D., Finegold D.N. A defect in sodium-dependent amino acid uptake in diabetic rabbit peripheral nerve. Correction by an aldose reductase inhibitor or myo-inositol administration. J Clin Invest. 85:1990;1657-1665.
57. Keller J.N., Mark R.J., Bruce A.J., Blanc E., Rothstein J.D., Uchida K., Waeg G., Mattson M.P. 4-Hydroxynonenal, an aldehydic product of membrane lipid peroxidation, impairs glutamate transport and mitochondrial function in synaptosomes. Neuroscience. 80:1997;685-696.